DPF2读取基因素乳酸化以驱动转录和瘤发生
Guijin Zhai1, Ziping Niu1, Zixin Jiang1
1The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
由于代谢变化,氨酸乳酸化 (Kla),一个基因素标记,在宫癌中升高. 研究人员确定DPF2是H3K14la的读者蛋白,将这种标记与癌症基因表达和生存联系起来.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 氨酸乳化 (Kla) 是一种新兴的组织蛋白修饰,参与基因转录.
- 胰岛素乳糖化在癌症中的作用,特别是识别其读者蛋白质,仍然在很大程度上是未知的.
研究的目的:
- 为了研究基因素乳化在宫癌中的作用.
- 在癌细胞中识别与乳酸化组合素结合的蛋白质,特别是H3K14la.
主要方法:
- 使用多价值光亲和探测器和定量蛋白质组学来识别H3K14la读者蛋白.
- 进行生物化学研究和CUT&Tag分析以验证蛋白质相互作用和基因组定位.
- 采用结构引导突变来破坏已识别的蛋白质 - 希斯相互作用.
主要成果:
- 宫癌细胞表现出由代谢重编程驱动的激素乳糖化增加,特别是H3K14la.
- DPF2被确定为H3K14la.的直接结合伙伴.
- 在致癌基因的促进者上,DPF2与H3K14la共定位.
- 破坏DPF2-H3K14la相互作用减少了与癌症相关的基因表达和细胞存活率.
结论:
- DPF2充当H3K14la的读者蛋白,功能性地将基因母乳化与基因转录和子宫癌中的细胞存活联系起来.
- 这些发现提供了关于瘤发生过程中基因素乳化机制的见解,并表明了潜在的治疗点.
更多相关视频
07:20Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy
Published on: October 18, 2024
10:09Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
相关概念视频
Abnormal Proliferation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Epigenetic Regulation
X-chromosome...
Spreading of Chromatin Modifications
Writers
The writer...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
